University of Virginia Center for the Study of Complementary and Alternative Therapies
Charlottesville, Virginia, 22908, United States
NCT Number: NCT00928720
The purpose of this study is to determine the effects of mild cranial electrical stimulation on pain, fatigue, sleep disturbances, perceived stress, blood pressure, and functional status in persons with fibromyalgia.
Looking for future studies?
Notify Me18 year and older
All sexes
Interventional
Not applicable
Charlottesville, Virginia, 22908, United States
Central pain networks in the brain are dysregulated in persons with fibromyalgia (FM). Thus, the investigators propose that cranial electrical stimulation (CES) that works on the brain may ameliorate symptoms of FM by interacting with the central pain networks. The specific aims of this randomized, controlled, three-group pilot study design are to: (1) determine differences in pain over time between the active CES, sham device, and usual care (UC) groups; (2) explore differences in brain activity in pain processing regions (i.e., cingulate, insula, prefrontal and somatosensory cortices, amygdala, and thalamus) between the active CES, sham device, and UC groups in a subset of 12 participants (6 in each device group); (3) determine the effects of CES on other symptoms (fatigue, sleep disturbances, depression, perceived stress) and functional status, and blood pressure over time between the active CES, sham device, and UC groups; and (4) determine the amount of influence that selected psychological factors (negative affect, catastrophizing, and other personality characteristics) have on group differences in pain, other symptoms, functional status, and brain activity.
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
(all participants):
Exclusion criteria
(subset of 12 participants who wil have fMRIs):
Participants will use the device for 60 continuous minutes each day for 8 weeks. The CES device will be preset at the factory to provide a maximum of 60 minutes of modified square-wave biphasic stimulation at 0.5 Hz and 100µA, the lowest setting that has been used in previous studies with patients with FM.
Other names: Alpha-Stim
The sham device will look the same as the active CES (Alpha-Stim); however, no electrical stimulation will be present in the sham device.
Time frame: week 8
A Numeric Rating Scale ranging from 0 (no pain) to 10 (worst pain imaginable) to capture present pain intensity
Time frame: Week 8
A Numeric Rating Scale ranging from 0-10 to capture present levels of fatigue using the fatigue subscale of Lee's Fatigue Scale
Time frame: Week 8
Time frame: Week 8
Time frame: Week 8
Time frame: Week 8
University of Virginia
Other
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT03705910
Behavior, Behavioral Symptoms
Famagusta, Cyprus
View Trial DetailsNCT04476316
Anxiety, Anxiety Disorders
Barcelona, Spain
View Trial DetailsNCT00524420
Behavior, Behavioral Symptoms
Seattle, Washington, United States
View Trial DetailsNCT07525063
Behavior, Behavioral Symptoms
Durham, North Carolina, United States
View Trial Details